Among the largest 'Vertically Integrated' pharmaceutical companies in India, Aurobindo has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations and has Global presence with own infrastructure, strategic alliances, subsidiaries & joint ventures. Aurobindo’s R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo develops new drug delivery systems, dosage formulations and applies new technology for better processes.
Looking for a particular Aurobindo Pharma employee's phone or email?
The Aurobindo Pharma annual revenue was $3.5 billion in 2026.
Dilip Kastala is the Chief Information Officer - Aurobindo Biologics of Aurobindo Pharma.
4,598 people are employed at Aurobindo Pharma.
Aurobindo Pharma is based in Hyderabad, Telangana.
The NAICS codes for Aurobindo Pharma are [32541, 32, 3254, 325].
The SIC codes for Aurobindo Pharma are [28, 283].